Experimentswith RIP3−/− fibroblasts and macrophages have shown thatNF-κB is unaffected.22 Although these reports are certainly valid underphysiological conditions, these findings need to be explored in cancer cellswhere NF-κB is frequently enhanced and deregulated. This evidence concerns the gene NFKB1 and cancer.